heparin-related pentasaccharide possessing selective factor Xa inhibitory activity, was prepared by a new synthetic pathway. This route was based on a [2+3] block synthesis utilizing a 6-O-silyl-protected l-idose-containing trisaccharide acceptor, which was glycosylated with a disaccharide donor containing a non-oxidized precursor of the glucuronic acid. The unique strategy of multiple functionalizations
通过新的合成途径制备了具有完全选择性的Xa抑制活性的完全O-
硫酸化,O-甲基化,
肝素相关的五糖Idraparinux 。该途径基于利用6 - O-甲
硅烷基保护的含1 -ID糖的三糖受体的[2 + 3]嵌段合成,所述三糖受体被含有
葡糖醛酸的非氧化前体的二糖供体糖基化。在五糖
水平上进行多种功能化的独特策略,涉及三甲基化,然后将
葡萄糖和同糖前体氧化为d-
葡萄糖醛酸和l一步法证明β-异戊糖酸是高效的,通过从d-
葡萄糖和甲基α- d-
吡喃
葡萄糖苷开始的39步合成来提供目标五糖。